Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrick Gray Insider Profile
4 Followers
Patrick Gray, Director at Civitas, holds 3.33K shares in Dicerna Pharma (Ticker: DRNA), holds 0.00 shares in Civitas (Ticker: ~CIVI).
Patrick Gray Civitas (~CIVI)Director
Civitas (~CIVI)
Director
Not Ranked
Patrick Gray has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Patrick Gray does not currently own shares as a corporate insider.
A breakdown of Patrick Gray's holdings
Insider Roles
Patrick Gray does not currently hold a role as a corporate insider.
Roles that Patrick Gray holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Patrick Gray
Patrick Gray's Trading History
Civitas
Mar 12, 2019
―
Uninformative Sell
―
$0.00
Dicerna Pharma
Jun 07, 2021
―
Uninformative Buy
―
$127.39K
List of latest transactions for each holding click on a transaction to see Patrick Gray's performance on stock
You May Also Like
Patrick Gray insider profile FAQ
What is the percentage of profitable transactions made by Patrick Gray?
The percentage of profitable transactions made by Patrick Gray is ―.
What is the average return per transaction made by Patrick Gray?
The average return per transaction made by Patrick Gray is ―.
What stocks does Patrick Gray hold?
Patrick Gray holds: ~CIVI, DRNA stocks.
What was Patrick Gray’s latest transaction?
Patrick Gray latest transaction was an Uninformative Buy of ―.
What was Patrick Gray's most profitable transaction?
Patrick Gray’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Patrick Gray's role in Civitas?
Patrick Gray's role in Civitas is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.